Research member Dr. Bertrand Routy, postdoctoral student Meriem Messaoudene and their team have published a study in the journal Cancer Discovery showing the anti-cancer benefits of the Brazilian camu-camu berry. Castalagin, a molecule from the Amazonian fruit, increases the effectiveness of immunotherapy by altering the microbiome.
The results of this study will allow clinical trials to begin. Castalagin will be used as an adjunct to drugs in certain cancer patients.
Thomas Gervais’ Discovery Named One of Québec Science’s Top 10 of 2021
18 January 2022
Research member Thomas Gervais, a full professor in the Department of Engineering Physics at Polytechnique Montreal, and his team have […]
Francis Rodier wins the 2019 Excellence Award
23 January 2020
The Montreal Cancer Institute congratulates Francis Rodier, who won the 2019 Excellence Award – Scientific Contribution of the Year 2019 […]